Zobrazeno 1 - 10
of 18
pro vyhledávání: '"Yi-Qian Lin"'
Publikováno v:
Key Engineering Materials. 753:300-304
The HLLS (high liquid limit soil) has the characteristics of high moisture content, low bearing capacity and poor water stability. Most of the existing treatment methods focus on the improvement with a single curing agent, and the research on the imp
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d49093cc2d2d77418a5417499fecc643
https://doi.org/10.4028/www.scientific.net/kem.753.300
https://doi.org/10.4028/www.scientific.net/kem.753.300
Autor:
Dong-Chu Zhang, Li-Ren Wang, Yi-Qian Lin, Wen-Yue Liu, Gui-Qi Zhu, Shengjie Wu, Ming-Hua Zheng, Martin Braddock
Publikováno v:
Oncotarget
Objectives To evaluate the association between sex-specific serum high sensitive C reactive protein (hsCRP) levels and NAFLD in a large population-based study. Results From Q1 to Q4, the incidence ratios were 21.1 (95% CI 17.5 24.7), 18.6 (95% CI 16.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::40ab177d5298bd13c2d36c8db4aefe8e
http://europepmc.org/articles/PMC4924711
http://europepmc.org/articles/PMC4924711
Autor:
Ke-Qing Shi, Yong-Ping Chen, Gui-Qi Zhu, Yi-Qian Lin, Li-Ren Wang, Martin Braddock, Ming-Hua Zheng, Mengtao Zhou, Gui-Qian Huang
Publikováno v:
Oncotarget
Objectives Therapies for treatment of patients with primary sclerosing cholangitis (PSC) include administration of ursodeoxycholic acid (UDCA) alone, or combination with metronidazole (MTZ) or mycophenolate mofetil (MMF), respectively. However, the o
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::21013819f3ba92eb847fe3b3947a3c8f
https://doi.org/10.18632/oncotarget.5610
https://doi.org/10.18632/oncotarget.5610
Autor:
Li-Ren Wang, Jiang-Tao Wang, Li Wan, Ka-Te Huang, Ming-Hua Zheng, Yi-Qian Lin, Gui-Qi Zhu, Liang-Liang Pan, Wen-Yue Liu, Martin Braddock
Publikováno v:
Cytotherapy. 17:1015-1024
Allogeneic transplantation is the definitive treatment for patients with end-stage liver disease but is limited by donor shortage and very high cost. Through de-cellularization and re-cellularization methods, re-engineered liver may provide a promisi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d3ebd6f8fd1ade145918b96e9efdd98f
https://doi.org/10.1016/j.jcyt.2015.04.003
https://doi.org/10.1016/j.jcyt.2015.04.003
Autor:
Martin Braddock, Yong-Ping Chen, Jiang-Tao Wang, Li-Ren Wang, Yi-Ming Wu, Mengtao Zhou, Sha Huang, Gui-Qian Huang, Yi-Qian Lin, Ke-Qing Shi, Ming-Hua Zheng, Zhi-Rui Zhou, Gui-Qi Zhu
Publikováno v:
Oncotarget
Objective Most comprehensive treatments for PBC include UDCA, combination of methotrexate (MTX), corticosteroids (COT), colchicine (COC) or bezafibrate (BEF), cyclosporin A (CYP), D-penicillamine (DPM), methotrexate (MTX), or azathioprine (AZP). Sinc
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::dd666c72b7c6379ca18c8db91909b0e5
https://doi.org/10.18632/oncotarget.4528
https://doi.org/10.18632/oncotarget.4528
Autor:
Xian-Feng Lin, Hui Wang, Jiang-Tao Wang, Ming-Hua Zheng, Yi-Qian Lin, Li-Ren Wang, Martin Braddock, Gui-Qi Zhu, Ming Zhong, Wen-Yue Liu
Publikováno v:
Expert Review of Neurotherapeutics. 15:493-500
Decellularization methodologies have been successfully used in a variety of tissue engineering and regenerative technologies and methods of decellularization have been developed for target tissues and organs of interest. The technology to promote reg
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::99eeb7d37721237c8d1232a6db783324
https://doi.org/10.1586/14737175.2015.1030735
https://doi.org/10.1586/14737175.2015.1030735
Autor:
Jiang-Ping He, Li-Ren Wang, Martin Braddock, Yong-Ping Chen, Ming-Hua Zheng, Yi-Qian Lin, Ke-Qing Shi, Ling-Fei Li
Publikováno v:
Gene. 544:101-106
Hepatitis C virus (HCV) infection is the major cause of chronic liver disease after renal transplantation (RT), which reduces both graft and patient survival. After RT, the most widely used approach is interferon (IFN)-based therapy of hepatitis C wh
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a370cf6c0de52e2aa27c448a75168cee
https://doi.org/10.1016/j.gene.2014.04.072
https://doi.org/10.1016/j.gene.2014.04.072
Autor:
Gui-Qi Zhu, Li-Ren Wang, Jiang-Tao Wang, Hui Wang, Ming-Hua Zheng, Yi-Qian Lin, Wen-Yue Liu, Liang-Liang Pan, Martin Braddock
Publikováno v:
Cytotherapy. 18(2)
The prevalence of end-stage renal disease is emerging as a serious worldwide public health problem because of the shortage of donor organs and the need to take lifelong immunosuppressive medication in patients who receive a transplanted kidney. Recen
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::57d2223db9c7732d46619b85a9baac71
https://pubmed.ncbi.nlm.nih.gov/26596504
https://pubmed.ncbi.nlm.nih.gov/26596504
Autor:
Yi-Qian Lin, Jiang-Tao Wang, Ming-Hua Zheng, Wen-Yue Liu, Liang-Liang Pan, Martin Braddock, Gui-Qi Zhu, Li-Ren Wang
Publikováno v:
Expert review of gastroenterologyhepatology. 9(9)
Techniques for producing decellularized scaffolds for use in liver tissue engineering are emerging as promising methods for tissue reconstruction. In this article, the authors present an overview of liver decellularization methods developed and appli
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fb69950e8b6a856b52f5aaa9de5f153b
https://pubmed.ncbi.nlm.nih.gov/26220044
https://pubmed.ncbi.nlm.nih.gov/26220044
Autor:
Gui-Qi Zhu, Sha Huang, Zhi-Rui Zhou, Ke-Qing Shi, Martin Braddock, Yong-Ping Chen, Ming-Hua Zheng, Gui-Qian Huang, Yi-Qian Lin
Publikováno v:
Medicine
Supplemental Digital Content is available in the text
Major ursodeoxycholic acid (UDCA)-based therapies for primary biliary cirrhosis (PBC) include UDCA only, or combined with either methotrexate (MTX), corticosteroids (COT), colchicine (COC), o
Major ursodeoxycholic acid (UDCA)-based therapies for primary biliary cirrhosis (PBC) include UDCA only, or combined with either methotrexate (MTX), corticosteroids (COT), colchicine (COC), o
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::65b561eb7e140ce47a90875392443027
http://europepmc.org/articles/PMC4602497
http://europepmc.org/articles/PMC4602497